NEWS

American Baby magazine feature on PAL® – December 2012

Monday, January 7th, 2013

 

 

 
See the article here:
American Baby, December 2012

 

 

 

 

 

 

 

Powers-DT Selects CoMedical, Inc. and Alamo Scientific, Inc. as Regional Distribution Partners in the U.S. for PAL®

Monday, January 7th, 2013

For Immediate Release
Contacts:
Patricia Palmer, President and CEO of Powers Device Technologies, Inc.
pat@powersdt.com, 917-696-1190
Griff Overturf, Vice President for Sales for CoMedical, Inc.
go@comedical.com, 206-669-5795
Todd Endersby, CEO of Alamo Scientific, Inc.
Todd@alamoscientific.com, 210-543-1300

St. Augustine, FL, December 19, 2012 – Powers Device Technologies, Inc. today announced the selection of CoMedical, Inc. and Alamo Scientific, Inc. to extend the availability of the Pacifier Activated Lullaby (PAL®) to Neonatal Intensive Care Units in the Southwest and Northwest.
PAL® is an FDA-approved, patented system that utilizes music reinforcement therapy to stimulate non-nutritive sucking and the breathe-suck-swallow reflex.  Premature infants come into the world before they have a chance to achieve this major developmental milestone on which their survival depends.  The PAL® technology represents a life-altering experience for these very vulnerable infants and it also serves to reduce their hospital length of stay and their readmission rates – both measurable and real cost savings to the hospital.

“We are honored to partner with CoMedical and Alamo Scientific as we strive to give these infants a healthier, quicker and stronger start on life,” said P. Kathleen Lovell, President and CEO of Powers Device Technologies, Inc.  “CoMedical and Alamo Scientific provide the in-depth market knowledge, the comprehensive product experience and the dedicated support their customers know and value.”

“It’s not often, in the emerging medical device market, that we come across ‘new’ products that already have substantial documented use, studies, and with hospitals reporting qualifying reimbursement,” said Todd Endersby, CEO of Alamo Scientific, Inc. and Doug Overturf, President and Founder of CoMedical, Inc.  “It is for those reasons and our presence within the NICU that we have chosen to partner with Powers Device Technologies to bring the PAL® technology to our customers.”

About CoMedical, Inc.
CoMedical, Inc. was founded in 1980 and is headquartered in Seattle, Washington.  CoMedical covers the Northwest including the states of Washington, Oregon, Idaho, Montana, Wyoming, Hawaii and Alaska. They represent the small innovative manufacturer by offering them a means to have their products introduced to the healthcare professional. CoMedical has a clear understanding of their customers’ needs and the value of their manufacturers’ products. Their goal is to merge these needs and value. More info: http://www.comedical.com/

About Alamo Scientific, Inc.
Alamo Scientific, Inc. specializes in bringing to market leading medical inventions, aimed at better patient care, servicing the wholesale healthcare market for Texas, Oklahoma, Arkansas, Louisiana, Mississippi and Alabama. Founded in 2005, Alamo has quickly built a highly respected reputation with both device manufacturers and leading hospitals within their service geography. More info: http://www.alamoscientific.com/

About Powers Device Technologies, Inc.
Powers-DT is developing feedback sensor products to address the nutritional and distress tolerance needs of premature and low birth weight infants.  Pre-term infants using PAL® learn to suck productively and feed successfully through groundbreaking feedback sensor technology – bringing music therapy and technology together to foster and support developmental milestones. More info: http://powersdt.com/

###

WFSU-FM Radio: Singing Pacifier Helps Babies Grow

Wednesday, November 21st, 2012

Listen to PAL® in this WFSU-FM Radio Story
Aired: November 14, 2012

PAL® featured by Tallahassee Magazine

Wednesday, November 21st, 2012

A Real PAL® For NICU Babies at TMH
Tallahassee Magazine, November/December 2012

Florida Hospital for Children Receives Pacifier Activated Lullaby Device Donation

Thursday, November 15th, 2012

Premature Infants at Orlando’s Most Advanced NICU to Benefit from Groundbreaking Invention

ORLANDO, Fla., November 8, 2012, — Powers Device Technologies Inc. proudly announced the donation of a new Pacifier Activated Lullaby (PAL®) medical device to Florida Hospital for Children’s Neonatal Intensive Care Unit (NICU). The PAL® device utilizes therapeutic music to strengthen and coordinate sucking, allowing premature infants to feed effectively and gain weight, which can lead to them going home sooner. Florida Hospital for Children is the only hospital in the Central Florida area to utilize this unique technology.

“We are thrilled to be able to receive our second PAL® at Florida Hospital for Children. We have had such success with this program since 2007 and cannot wait to have the ability to extend this service to more premature infants,” said Amy Robertson, Florida Hospital board certified musical therapist. “This not only allows us to send home these infants sooner, but it creates the opportunity for the mother to be with their child during the treatments, allowing them to bond.”

The PAL® device supports earlier discharge from the NICU and decreases readmission rates for feeding-related issues. Thanks to innovative thinking and cutting-edge technology, Powers Device Technologies has brought the benefits of PAL® to the commercial market.

“Florida Hospital has been a key partner in proving how effective the PAL® technology is at solving developmental issues in preterm infants,” said P. Kathleen Lovell, president and CEO of Powers Device Technologies. “I am honored to donate one of our PAL® units to such a talented and dedicated NICU and I am looking forward to hearing about their successes with the device in the years to come.”

Florida Hospital music therapists check out the brand new Pacified Activated Lullaby (PAL®) device donated by Powers Device Technologies, Inc.

The PAL® was invented by Florida State University researcher Jayne Standley, Ph.D. Originally envisioned by Dr. Standley more than a decade ago, PAL® has undergone extensive testing, received a U.S. patent and been approved by the Food and Drug Administration. Research studies have shown that PAL® can reduce the length of a premature infant’s hospital stay by an average of five days.

Florida Hospital for Children’s Neonatal Intensive Care Unit (NICU) is an 81-bed Level III unit that allows Florida Hospital to deliver a complete range of dedicated health services back by the most advanced technologies and care to NICU patients, who benefit from the expertise of specialized departments throughout the hospital.

For media inquiries only, contact Florida Hospital Media Relations at 407-303-8217. 

www.floridahospitalnews.com

www.powersdt.com

###